BioCentury
ARTICLE | Clinical News

NCX 6560: Preliminary Phase Ib data

November 23, 2009 8:00 AM UTC

Top-line data from a 3-part, double-blind Phase Ib trial in 88 male subjects showed that NCX 6560 was well tolerated, with the highest dose of the product showing a similar safety profile to Lipitor ...